| Analysis | Metabolite Name | Measured Value | Units | Construct |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | CREATINE (CAS# 57-00-1); (M-H)- | 5455 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | CREATINE (CAS# 57-00-1); (M-H)- | Peak area | Control lentivirus | |
| Reversed phase NEGATIVE ION MODE | CREATINE (CAS# 57-00-1); (M-H)- | Peak area | Noxa knockdown | |
| Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 1624853 | Peak area | Noxa knockdown |
| Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 1850609 | Peak area | Noxa knockdown |
| Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 1895383 | Peak area | Noxa knockdown |
| Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 2758032 | Peak area | Control lentivirus |
| Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 2850447 | Peak area | Control lentivirus |
| Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 3198698 | Peak area | Control lentivirus |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|